Quick Answer
Adaptive Biotechnologies Corp reported Total Assets of $512.74 million for fiscal year 2025.
Adaptive Biotechnologies Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $512.74M | -4.9% |
| 2024 | $539.38M | -18.4% |
| 2023 | $661.13M | -22.8% |
| 2022 | $856.62M | -7.2% |
| 2021 | $923.34M | -17.3% |
| 2020 | $1.12B | +22.4% |
| 2019 | $912.30M | +174.2% |
| 2018 | $332.69M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $490.61M | -12.2% | -1.2% |
| June 30, 2025 | $496.64M | -15.1% | -2.8% |
| March 31, 2025 | $510.85M | -17.6% | -5.3% |
| December 31, 2024 | $539.38M | -18.4% | -3.4% |
| September 30, 2024 | $558.51M | -22.2% | -4.5% |
| June 30, 2024 | $584.87M | -23.5% | -5.7% |
| March 31, 2024 | $620.32M | -21.6% | -6.2% |
| December 31, 2023 | $661.13M | -22.8% | -7.9% |
- Adaptive Biotechnologies Corp showed a decrease of -4.9% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Adaptive Biotechnologies Corp’s total assets has grown by 54.1% (from $332.69 million to $512.74 million).
- The most recent figure is from Adaptive Biotechnologies Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: